Altimmune, Inc., a clinical-stage biopharmaceutical company, announced it will be added to the Nasdaq Biotechnology Index effective December 23, 2024. This milestone marks a significant achievement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback